![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
N Adham, B Ellerbrock, P Hartig, RL Weinshank and T Branchek
Synaptic Pharmaceutical Corporation, Paramus, New Jersey 07652.
The present study was undertaken to evaluate the behavior of the rat 5- hydroxytryptamine (5-HT)1B receptor stably expressed in a Y-1 cell line, using both radioligand binding ([125I]iodocyanopindolol) and functional assays (inhibition of forskolin-stimulated cAMP release). The measured EC50 values for agonists were lower than expected from the measured Ki values (e.g., 5-HT, EC50 = 0.49 +/- 0.043, nine experiments; Ki = 5.3 +/- 0.82, four experiments). Furthermore, beta- adrenergic antagonists such as propranolol and pindolol, which have been reported to be partial agonists or antagonists at the 5-HT1B receptors in other systems, were found to be full agonists. To investigate the relationship between receptor occupancy and inhibition of cAMP release (and hence the degree of receptor reserve), we used the irreversible receptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2- dihydroquinoline (EEDQ). EEDQ treatment shifted the dose-response curve for 5-HT to the right by 6-7-fold, accompanied by a reduction (30-50%) in maximal response. Analysis of the data by the method of Furchgott revealed a very steep hyperbolic relationship between receptor occupancy and response for 5-HT, with 92 +/- 1.4% (three experiments) receptor reserve at the 50% maximal response level. In contrast to its effect on 5-HT, EEDQ treatment did not significantly shift the dose- response curves for pindolol; rather, only the maximal responses were reduced and a linear relationship was found between receptor occupancy and response for this compound. According to classical receptor theory these data indicate that pindolol is a partial agonist, relative to 5- HT, but because of the high density of 5-HT1B receptors in this system the difference between the intrinsic activities of the two drugs is masked. Therefore, one has to be cautious when interpreting functional data in transfected systems that often display large receptor reserve.
This article has been cited by other articles:
|
|
 |
|
  J. Bodenstein, D. P. Venter, and C. B. Brink Phenoxybenzamine and Benextramine, but Not 4-Diphenylacetoxy-N-[2-chloroethyl]piperidine Hydrochloride, Display Irreversible Noncompetitive Antagonism at G Protein-Coupled Receptors J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 891 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Gay, J. D. Urban, D. E. Nichols, G. S. Oxford, and R. B. Mailman Functional Selectivity of D2 Receptor Ligands in a Chinese Hamster Ovary hD2L Cell Line: Evidence for Induction of Ligand-Specific Receptor States Mol. Pharmacol., July 1, 2004; 66(1): 97 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Niedernberg, S. Tunaru, A. Blaukat, B. Harris, and E. Kostenis Comparative Analysis of Functional Assays for Characterization of Agonist Ligands at G Protein-Coupled Receptors J Biomol Screen, October 1, 2003; 8(5): 500 - 510. [Abstract] [PDF]
|
|
|
|
|
|
A. Newman-Tancredi, V. Audinot, C. Moreira, L. Verrièle, and M. J. Millan Inverse Agonism and Constitutive Activity as Functional Correlates of Serotonin h5-HT1B Receptor/G-Protein Stoichiometry Mol. Pharmacol., November 1, 2000; 58(5): 1042 - 1049. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. A. Cleland and C. Linster Concentration Tuning Mediated by Spare Receptor Capacity in Olfactory Sensory Neurons: A Theoretical Study Neural Comput., October 1, 1999; 11(7): 1673 - 1690. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Pineyro and P. Blier Autoregulation of Serotonin Neurons: Role in Antidepressant Drug Action Pharmacol. Rev., September 1, 1999; 51(3): 533 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Newman-Tancredi, D. Cussac, V. Audinot, V. Pasteau, S. Gavaudan, and M. J. Millan G Protein Activation by Human Dopamine D3 Receptors in High-Expressing Chinese Hamster Ovary Cells: A Guanosine-5'-O-(3-[35S]thio)-Triphosphate Binding and Antibody Study Mol. Pharmacol., March 1, 1999; 55(3): 564 - 574. [Abstract] [Full Text]
|
|
|
|
|
|
L. W. Fitzgerald, J. P. Patterson, D. S. Conklin, R. Horlick, and B. L. Largent Pharmacological and Biochemical Characterization of a Recombinant Human Galanin GALR1 Receptor: Agonist Character of Chimeric Galanin Peptides J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 448 - 456. [Abstract] [Full Text]
|
|
|
|
|
|
A. Newman-Tancredi, V. Audinot, C. Chaput, and L.V. a. M. J. Millan [35S]Guanosine-5'-O-(3-thio)triphosphate Binding as a Measure of Efficacy at Human Recombinant Dopamine D4.4 Receptors: Actions of Antiparkinsonian and Antipsychotic Agents J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 181 - 191. [Abstract] [Full Text]
|
|
|
|
|
|
T. Tsuda, T. Kusui, W. Hou, R. V. Benya, M. A. Akeson, G. S. Kroog, J. F. Battey, and R. T. Jensen Effect of Gastrin-Releasing Peptide Receptor Number on Receptor Affinity, Coupling, Degradation, and Modulation Mol. Pharmacol., May 1, 1997; 51(5): 721 - 732. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. G. Ni, N. Camacho, and R. Miledi Irreversible antagonism of 5HT2c receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) PNAS, March 18, 1997; 94(6): 2715 - 2718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Gether, S. Lin, and B. K. Kobilka Fluorescent Labeling of Purified beta(2) Adrenergic Receptor J. Biol. Chem., November 24, 1995; 270(47): 28268 - 28275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhou, V. Rodic, S. Kitanovic, C. A. Flanagan, L. Chi, H. Weinstein, S. Maayani, R. P. Millar, and S. C. Sealfon A Locus of the Gonadotropin-releasing Hormone Receptor That Differentiates Agonist and Antagonist Binding Sites J. Biol. Chem., August 11, 1995; 270(32): 18853 - 18857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Moret and M. Briley The unique effect of methiothepin on the terminal serotonin autoreceptor in the rat hypothalamus could be an example of inverse agonism J Psychopharmacol, January 1, 1993; 7(4): 331 - 337. [Abstract] [PDF]
|
|
|
|
|
|
V. Audinot, P. Beauverger, C. Lahaye, T. Suply, M. Rodriguez, C. Ouvry, V. Lamamy, J. Imbert, H. Rique, J.-L. Nahon, et al. Structure-Activity Relationship Studies of Melanin-concentrating Hormone (MCH)-related Peptide Ligands at SLC-1, the Human MCH Receptor J. Biol. Chem., April 20, 2001; 276(17): 13554 - 13562. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
